9/1/2026
Barrow, ASU launch clinical trial for ibogaine in the US
The study aims to explore ibogaine's potential for treating PTSD and addiction.
Topic archive
7 stories
9/1/2026
The study aims to explore ibogaine's potential for treating PTSD and addiction.
8/19/2026
Barrow Neurological Institute to test ibogaine's safety and efficacy in a state-funded trial.
8/19/2026
Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.
8/10/2026
Arizona funds first U.S. ibogaine trial for traumatic brain injuries, starting 2027.
8/6/2026
The trial will explore ibogaine's potential to treat traumatic brain injury, starting in 2027.
8/6/2026
The trial will explore ibogaine's potential in treating chronic TBI symptoms.
8/6/2026
Arizona-funded study explores ibogaine's potential for neurological disorders.